node only. A small bowel enema showed thickened terminal ileum folds which was confirmed on CT-scan. A duodenal biopsy was negative for alpha-heavy chain positive, immunoproliferative small intestinal disorder (IPSID) or lymphoma. Colonoscopy was normal, and colonic and terminal ileum biopsies showed no evidence of tuberculosis or lymphoma. Screening tests for collagen vascular disease were negative. T-Iymphocyte function was slightly impaired in keeping with a chronic infectious disease, and the HIV screens were negative. In view of the negative histology the patient was discharged to be closely followed-up as an outpatient.
The brown bowel syndrome (BBS), so called because of the accumulation of lipofuscin in the intestinal smooth muscle layer, is a rare condition occurring in association with vitamin E deficiency and leads to atrophy of the intestinal smooth muscle. We report a case of BBS in a coeliac presenting with massive lower gastrointestinal bleeding, a complication not previously recognized in this condition, which shows lipofuscin deposition in vascular smooth muscle may have been the predisposing factor.
Journal of the Royal Society of Medicine Volume 84 July 1991 437 diagnostic approach in such patients in whom the diagnosis remains elusive. The hallmark of diagnosis is the finding of caseating granuloma and/or AFB on histology or culture of the intestinal lesion', These rigid criteria have been extended to include an unequivocal response to anti-TB treatment in patients with clinical, radiological and/or operative evidence of intestinal TB associated with histologically-proven TB elsewhere". The diagnosis in our patient was made on the latter basis.
The one-year delay in establishing the diagnosis in our case raises the question as to whether laparotomy should not have been undertaken during earlier admissions. Laparotomy remains the definitive investigation in many patients with intestinal TB1.2. The question also arises as to whether a therapeutic trial with anti-TB therapy is warranted in some patients with suspected intestinal TB in whom the diagnosis ofTB cannot be readily established", This approach may be of both diagnostic and therapeutic value, and is practised in most endemic areas. References Case report A 58-year-old man was transferred from a peripheral hospital with a 2-day history of passing large amounts offresh blood per rectum. There was no associated abdominal pain. He had required seven units of blood in the 24 h prior to transfer. The patient had no past history of gastrointestinal bleeding but was a known coeliac. On admission the patient was pale, pulse nO/min, blood pressure 90/60. Abdominal examination was normal, rectal examination confirmed fresh blood but no mass was felt. His haemoglobin was 8.4 gldl, a COAG screen, plain film of the abdomen, chest X-ray and ECG were normal. The patient was resuscitated with a further three units of blood. Colonoscopy failed to demonstrate a bleeding point, but fresh blood was seen as far as the caecum. Emergency angiography was unavailable, and as the patient continued to bleed he had a total colectomy and ileostomy. He had no further bleeding and made a good postoperative recovery. A histological diagnosis of the brown bowel syndrome was made. 
Discussion
The BBS, a term first used to describe this condition in 1963 1, is characterized by a copper coloured bowel due to the accumulation of lipofuscin in the smooth muscle layer and atrophy and atony ofthe smooth muscle ( Figure 1 ). The brown bowel syndrome has previously been reported in association with coeliac diseases. It is due to malabsorption and is specifically associated with a deficiency of vitamin E 3 • Though the precise pathophysiology is unknown it is 0141-0768/91/ 070437-021$02.00/0 © 1991 The Royal Society of Medicine F Penin' F Bertrand" postulated that vitamin E has an important protective role in mitochondria preventing the unsaturated lipids of the mitochondrial membrane being damaged by free radicals formed during oxidative phosphorylatiorr'". Our patient was a coeliac of 11 years, a poor complier with his gluten free diet and had frequent bouts of steatorrhoea. His vitamin E level during admission was low, 5.6 ngll (normal range 9-14 ng/l). Lower gastrointestinal haemorrhage has not been described as a complication ofthe brown bowel syndrome. Lipofuscin deposition in vascular smooth muscle has only been occasionally documented", In this case histological sections through the mesentery revealed accumulation of lipofuscin in smooth muscle of the wall of the arteries and veins and it can be postulated that it is this defect in vascular smooth muscle that allowed massive haemorrhage to occur and continue.
In conclusion, while the brown bowel syndrome is rare it may present with massive lower gastrointestinal bleeding 5 q. Syndrome and monoclonal gammopathy with a1 antitrypsin deficiency C JeandeP J P Aymard" R L Hofmann" M George" M J Gregoire-G Cuny' CHU Nancy, Brabois, 54500, Vandoeuure Las Nancy,
France, lSeruice of Internal Medicine B, 2Regional Blood Transfusion and Haematology Centre, 3Department ofBiochemistry and St Charles Hospital
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We describe a patient who presented with 5 q-syndrome, monoclonal gammopathy of undetermined significance (MGUS) and a l antitrypsin (a l AT) deficiency and discuss the possible relations between these three abnormalities. To our knowledge this is the first such case in the medical literature.
Case report
An 86-year-old woman in previous good health was admitted to the hospital due to excessive fatigue. Physical examination was unremarkable. She denied any significant alcohol intake and did not smoke but there was a possible exposure to benzene. Routine blood tests disclosed a macrocytic anaemia (Hb: 9 gldl, MCV: 113 fl), white count of 2.3x10 9 /L (20% polymorphonuclear cells, 78% lymphocytes and 2% monocytes) and a platelet count of 220x 1Q9/L. Plasma B 12 , folate, and red cell folate were within normal limits. Serum calcium concentration was 2.12 mmolll. Liver function tests were normal. Serum protein electrophoresis showed sediment in gammaglobulin band and a marked decrease in the a l globulin band. An immunoelectrophoretic study detected an IgM monoclonal protein with kappa light chains. Quantitative immunoglobulin assays were IgG: 13.3 gil (normal, 7 to 16), IgA: 2.43 gil (normal, 0.9 to 3.3) and IgM: 8.29 gil (normal, 0.5 to 2.5). There were no osteolytic bone lesions on roentgenograms. The bone marrow aspirate was normocellular and showed a normal granulocytic series (42%) with 3% myeloblasts. The erythroid series was decreased (GIE ratio of 5.6) with evidence of disordered maturation and dyserythropoiesis. Among red cells, the proportion of sideroblasts was 35% with absence of ringed cells. A plasma-lymphocytic infiltration was apparent (lymphocytes: 40%, plasmacytes: 5%). The most striking finding was the occurrence of numerous unilobular nucleated megakaryocytes. The karyotype performed on bone marrow cells showed deletion of the long arm of chromosome and therefore one must seek and treat vitamin E deficiency in conditions causing malabsorption in an effort to prevent this condition. (Figure 1 ). No karyotypically abnormal lymphocytes were found in the peripheral blood. Serum al antitrypsin level was 36 mgldl (normal values: 140 to 340) and protease inhibitor typing showed the homozygous ZZ phenotype. Family history was negative for liver and pulmonary diseases. The patient had no significant history of pulmonary disease and no emphysema on thoracic CT scan. A liver biopsy was not performed.
Discussion
The 5 q-syndrome is a distinct myelodysplastic syndrome (MDS) with macrocytic anaemia, low to normal leukocyte count, normal or elevated platelet count, nonlobulated megakaryocytes, and a rather mild clinical course with only a small chance of evolving into an acute nonlymphatic leukaemia'. It occurs more often in women. The 5q-anomaly occurs predominantly in myeloproliferative disorders. Besides a few observations in solid tumours, this anomaly has also been found in lymphoproliferative conditions/. On the other hand, dysglobulinaemia associated with MDS with 5 q-anomaly is rarely described, except 5 q-syndrome induced by chemotherapy for the dysglobulinaemia". Only five cases have been reported; one case of multiple myeloma" and four cases of MGUS I ,4. The absence of the deleted chromosome in the lymphocytes of the peripheral blood indicates that the anomaly is an acquired one, occurring originally in a bone marrow stem cell. The chromosomally abnormal stem cell is able to follow erythroid, myeloid, megakaryocytic and possibly B lymphocytic differentiation". Thus, the acquisition of a 5 q-clone for myeloid and lymphocytic pathways could lead to simultaneous development ofMDS and MGUS. We cannot rule out the possibility that benzene may have induced 5 q-anomaly. What is more, the association between a l AT deficiency -genetically determined as regards the 0141·0768/91/ 070438·021$02.00/0 © 1991 The Royal Society of Medicine
